Nasdaq-Listed Acurx Invests $1M in Bitcoin—What's Behind the Move?
Acurx‘s $1 million Bitcoin investment is a major shift in treasury handling. The Nasdaq-listed biotech firm is one of many companies investing in Bitcoin. This strategy matches a wider pattern of companies adapting to rising support and cryptocurrency market volatility. Source: Nasdaq Also Read: Top 3 Cryptocurrencies On The Verge Of New All-Time Highs Why Acurx’s $1M Bitcoin Investment Signals Major Trends in Corporate Cryptocurrency Adoption Strategic Treasury Management Acurx bitcoin investment followed market research. “As demand for Bitcoin grows, and so does its acceptance as a major and primary asset class, we believe that Bitcoin will serve as a strong treasury reserve asset for cash not needed over the next 12 to 18 months,” stated David P. Luci, President & CEO of Acurx. Acurx Bitcoin Investment Market Response and Corporate Bitcoin Strategy Companies investing in Bitcoin saw proof of success. Acurx shares rose 6.6% to $1.78 before the market opened. T...